Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication.

Project Information

INPACT

Grant agreement ID: 644167

DOI

10.3030/644167

Project closed

EC signature date 19 November 2014

Start date 1 February 2015

End date 31 January 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 1 390 500,00

EU contribution

€ 850 500,00

Coordinated by

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Portugal

• Breaking down barriers to develop new anticancer drugs
  EN